Photo from wikipedia
Introduction The optimal antithrombotic treatment for patients with atrial fibrillation and acute coronary syndrome (ACS), whether or not treated with revascularization, is a complex and debated issue. Clinical practice guidelines… Click to show full abstract
Introduction The optimal antithrombotic treatment for patients with atrial fibrillation and acute coronary syndrome (ACS), whether or not treated with revascularization, is a complex and debated issue. Clinical practice guidelines are based on expert opinion – lacking strong evidence based on clinical trials – and recommend a personalized treatment balancing the atherothrombotic, thromboembolic and bleeding risks.
Keywords:
atrial fibrillation;
acute coronary;
fibrillation acute;
coronary syndrome
Journal Title: Journal of Cardiovascular Medicine
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Cardiovascular Medicine
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!